skip navigation

PUBLICATIONS

Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.

 

NCJ Number: 164704 Add to Shopping cart Find in a Library
Title: Final ONDCP Testimony on Reauthorization of ONDCP (M.14) -- Statement of Lee P Brown, Director, Office of National Drug Control Policy
Author(s): L P Brown
Date Published: 1993
Page Count: 20
Sponsoring Agency: National Institute of Justice/NCJRS
Rockville, MD 20849
NCJRS Photocopy Services
Rockville, MD 20849-6000
US Dept of Justice, Office of Justice Programs
Washington, DC 20531
Sale Source: National Institute of Justice/NCJRS
Box 6000
Rockville, MD 20849
United States of America

NCJRS Photocopy Services
Box 6000
Rockville, MD 20849-6000
United States of America
Type: Legislative Hearing/Committee Report
Language: English
Country: United States of America
Annotation: Testimony by the Director of the Office of National Drug Control Policy (ONDCP) at a 1993 hearing to consider reauthorization of the ONDCP is presented.
Abstract: The ONDCP was established by the Anti-Drug Abuse Act of 1988 to provide direction to the national drug control program. Although the ONDCP is involved in promulgating the National Drug Control Strategy, drug budget certification, the High Intensity Drug Trafficking Area Program, the Special Forfeiture Fund, and the Counter-Drug Technology Assessment Center, the ONDCP's role can be improved in several areas. The continued need for a central planning agency to direct the national drug control program is demonstrated. The importance of effective drug use measures and reliable data sources is noted, and the need to obtain information about drug market trends at the local level is emphasized. The testimony also considers improvements in measures designed to assess progress made under national drug control strategies, drug abuse prevention, drug treatment, and cooperation among Federal drug control agencies. The testimony further focuses on military involvement in drug law enforcement (surveillance and drug interdiction), drug courts, collaboration between the criminal justice and drug treatment communities, and duplication in domestic and international drug intelligence production efforts.
Main Term(s): Drug regulation
Index Term(s): Drug abuse; Drug Courts; Drug law enforcement; Drug prevention programs; Drug testing; Drug treatment programs; Intelligence acquisition; Military role in drug law enforcement
Note: DCC
To cite this abstract, use the following link:
http://www.ncjrs.gov/App/publications/abstract.aspx?ID=164704

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.